Apollo Endosurgery, Inc. (NASDAQ: APEN) is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. Apollo’s device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo’s products are offered in over 75 countries today and include the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, X-Tack Endoscopic HeliX Tacking System and the ORBERA Intragastric Balloon. Apollo’s common stock is traded on the Nasdaq Global Market under the symbol “APEN”. For more information, visit the company’s website at www.apolloendo.com
To view IBN’s virtual coverage of Apollo Endosurgery Inc. and other presenters at the Sidoti Microcap Conference, as well as gain access to additional conference information and registration, visit https://ibn.fm/SidotiMay2021Portal
Institutional, family office and high-net-worth investors, as well as RIAs, who wish to schedule a 1×1 meeting with the Company can contact the Sidoti conference team directly at [email protected]
About InvestorBrandNetwork’s Virtual Coverage
The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at the Sidoti Virtual Microcap Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.
For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]